2Bluna R, Vitetta E S. Vascular leak syndrome:a side effect of immunotherapy [J]. Immunopharmacology, 1997,37(2-3): 117-132.
3Pulkkanen K, Kataja V, Johansson R.Systemic capillary leak syndrome resulting from Gemcitabine treatment in renal cell carcinoma: a case report [J].J Chemotherapy, 2003,15 (3):287-289.
二级参考文献7
1Bluna R, Vitetta ES. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology, 1997,37:117 - 132.
2Cotran RS, Pober JS, Gimbrone MA, et al. Endothellal activation during interleukin 2 immunotherapy. J of Immunol, 1987,139:1883 - 1888.
3Dmle NK, Doyle LV. IL-2-activated human killer lymphocytes but not their secreted products mediated increase in albumin flux across cultured endothelial monolayers. J of Immunol, 1989,142: 2660 - 2669.
4Assaly R, Olson D, Hammersley J, et al. Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome.Chest, 2001,120:1301 - 1308.
5Raft AQ, Zeytun A, Bradley M J, et al. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J Immunol, 1998,161:3077 - 3086.
6Douglas J. Schwartzentruber. Guidelines for the safe administration of high-dose Interleukin-2. Journal of Immunotherapy, 2001,24:287 -293.
7Pulkkanen K. Systemic capillary leak syndrome resulting from Gemcitabine treatmeng in renal cell carcinoma: A case report. Journal of Chemotherapy,2003 ,15 :287 - 289.
5Usuki K,Urabe A,Ikeda Y,et al.A multicenter randomized,double-blind,placebo-controlled late-phase II/Ⅲstudy of recombinant human interleukin 11 in acute myelogenous leukemia[J].Int J Hematol,2007,85(1):59-69.
6张之南.沈第.血液病诊断及疗效标准[S].第2版.北京:科学出版社,1999:279-284.
7BaIlen K K,Beeker PS.Autologous 8tern-cell transplantation can be performed safely without the use of blood-product support[J].J Clin Oncol,2004,22:4087-4094.
8Littler E,Stuart AD,Chee MS. Human cytomegalovirus UI.97 open rdading trame encodes a protein that phosphorytates the antiviral mucleoside analogue ganciclovir [J].Nature, 1992, 358:160-162.
9Tian J. Hydroxyethyl starch and capillary leak syndrome[J]. Anesth Analg, 2004,98(3) : 768-774.
10Tsimberidou AM, Giles FJ, Khouri I, et al. Low-dose inter- leukin-11 in patients with bone marrow failure:update of the M. D. Anderson Cancer Center experience[J]. Ann Oncol, 2005,16(1) : 139- 145.
